Published in Br J Pharmacol on February 01, 2001
Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscle. Br J Pharmacol (2003) 0.93
Selective inhibition of thapsigargin-induced contraction and capacitative calcium entry in mouse anococcygeus by trifluoromethylphenylimidazole (TRIM). Br J Pharmacol (2001) 0.77
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
A model for receptor-regulated calcium entry. Cell Calcium (1986) 12.47
Capacitative calcium entry revisited. Cell Calcium (1991) 7.73
Store depletion and calcium influx. Physiol Rev (1997) 7.15
Capacitative calcium entry. Biochem J (1995) 6.16
Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (2000) 5.24
Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. Science (1999) 2.84
L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol (1990) 2.84
Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem (2000) 2.77
On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins. Proc Natl Acad Sci U S A (1996) 2.44
Capacitative calcium entry channels. Bioessays (1999) 2.37
A GTP-dependent step in the activation mechanism of capacitative calcium influx. J Biol Chem (1993) 2.15
Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun (1989) 1.97
Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem (1997) 1.62
Mechanism of nitric oxide-induced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx. Circ Res (1999) 1.56
Depletion of intracellular Ca2+ stores activates nitric-oxide synthase to generate cGMP and regulate Ca2+ influx. J Biol Chem (1994) 1.48
Cyclic GMP modulates depletion-activated Ca2+ entry in pancreatic acinar cells. J Biol Chem (1993) 1.41
Two distinct membrane currents activated by cyclopiazonic acid-induced calcium store depletion in single smooth muscle cells of the mouse anococcygeus. Br J Pharmacol (1996) 1.39
Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. Biochem Biophys Res Commun (1996) 1.38
Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J Biol Chem (1984) 1.32
cGMP and cAMP inhibit tension development in skinned coronary arteries. Pflugers Arch (1984) 1.28
Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase. J Biol Chem (1998) 1.26
N-methylhydroxylamine inhibits and M&B 22948 potentiates relaxations of the mouse anococcygeus to non-adrenergic, non-cholinergic field stimulation and to nitrovasodilator drugs. Br J Pharmacol (1989) 1.25
Nitric oxide inhibits capacitative cation influx in human platelets by promoting sarcoplasmic/endoplasmic reticulum Ca2+-ATPase-dependent refilling of Ca2+ stores. Circ Res (1999) 1.18
Capacitative Ca2+ entry and the regulation of smooth muscle tone. Trends Pharmacol Sci (1998) 1.18
Phosphorylation of myosin light chain kinase from vascular smooth muscle by cAMP- and cGMP-dependent protein kinases. J Mol Cell Cardiol (1985) 1.03
Cyclic GMP-dependent protein kinase relaxes skinned fibers from guinea pig taenia coli but not from chicken gizzard. Pflugers Arch (1986) 1.00
Prejunctional inhibition of non-adrenergic non-cholinergic transmission in the rat anococcygeus muscle. Eur J Pharmacol (1989) 1.00
Introduction of high molecular weight (IgG) proteins into receptor coupled, permeabilized smooth muscle. Cell Calcium (1994) 1.00
Variable potency of nitrergic-nitrovasodilator relaxations of the mouse anococcygeus against different forms of induced tone. Br J Pharmacol (1994) 0.98
Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism. J Biol Chem (2000) 0.97
Correlation between store-operated cation current and capacitative Ca2+ influx in smooth muscle cells from mouse anococcygeus. Eur J Pharmacol (1999) 0.93
Cellular mechanisms underlying carbachol-induced oscillations of calcium-dependent membrane current in smooth muscle cells from mouse anococcygeus. Br J Pharmacol (1997) 0.90
Role of cyclic GMP in the control of capacitative Ca2+ entry in rat pancreatic acinar cells. Biochem J (1995) 0.90
Thapsigargin-induced tone and capacitative calcium influx in mouse anococcygeus smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.89
Properties of the inactivating outward current in single smooth muscle cells isolated from the rat anococcygeus. Pflugers Arch (1992) 0.88
cGMP mediates corpus cavernosum smooth muscle relaxation with altered cross-bridge function. Life Sci (1998) 0.88
cGMP-dependent protein kinase decreases calcium sensitivity of skinned cardiac fibers. FEBS Lett (1982) 0.87
Depletion of either ryanodine- or IP3-sensitive calcium stores activates capacitative calcium entry in mouse anococcygeus smooth muscle cells. Pflugers Arch (1998) 0.84
Inhibitory mechanisms for cross-bridge cycling: the nitric oxide-cGMP signal transduction pathway in smooth muscle relaxation. Acta Physiol Scand (1998) 0.83
cGMP is not required for capacitative Ca2+ entry in Jurkat T-lymphocytes. Cell Calcium (1996) 0.81
Inhibition by sodium nitroprusside of a calcium store depletion-activated non-selective cation current in smooth muscle cells of the mouse anococcygeus. Br J Pharmacol (1996) 0.81
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol (1990) 7.27
Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science (2001) 5.45
Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature (1990) 5.41
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
Postinfectious fatigue: prospective cohort study in primary care. Lancet (1995) 5.21
Population based study of fatigue and psychological distress. BMJ (1994) 5.15
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11
Case-control study of sudden infant death syndrome in Scotland, 1992-5. BMJ (1997) 4.03
Does cryptic gluten sensitivity play a part in neurological illness? Lancet (1996) 3.92
GTPase activity of dynamin and resulting conformation change are essential for endocytosis. Nature (2001) 3.90
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet (1997) 3.29
In migrating fibroblasts, recycling receptors are concentrated in narrow tubules in the pericentriolar area, and then routed to the plasma membrane of the leading lamella. J Cell Biol (1994) 3.19
Teenagers' health concerns: implications for primary health care professionals. J R Coll Gen Pract (1989) 3.00
In polarized MDCK cells basolateral vesicles arise from clathrin-gamma-adaptin-coated domains on endosomal tubules. J Cell Biol (1998) 2.95
Use of a questionnaire in general practice to increase the recognition of patients with excessive alcohol consumption. Br Med J (Clin Res Ed) (1985) 2.85
Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract (2001) 2.76
The effect of immunosympathectomy and of 6-hydroxydopamine on the responses of the rat anococcygeus to nerve stimulation and to some drugs. Br J Pharmacol (1973) 2.57
Can telemedicine be used to improve communication between primary and secondary care? BMJ (1996) 2.55
What are safe levels of alcohol consumption? Br Med J (Clin Res Ed) (1984) 2.54
L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol (1991) 2.53
The risk of alcohol. Addiction (1993) 2.51
The state of basic surgical training in the UK: ophthalmology as a case example. J R Soc Med (2004) 2.51
The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health (1997) 2.47
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
A pilot study of sexual lifestyle in a random sample of the population of Great Britain. AIDS (1989) 2.13
L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. Br J Pharmacol (1990) 2.12
Transport into and out of the Golgi complex studied by transfecting cells with cDNAs encoding horseradish peroxidase. J Cell Biol (1994) 2.06
Safe limits of drinking: general practitioners' views. Br Med J (Clin Res Ed) (1985) 2.06
No news is bad news: patients' views about communication in hospital. Br Med J (1978) 2.00
7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol (1993) 1.97
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol (1994) 1.97
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet (2005) 1.94
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care (1992) 1.92
A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol (1999) 1.87
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest (1986) 1.87
Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract (1995) 1.86
Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet (1998) 1.83
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab (1997) 1.82
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest (1998) 1.82
Changing the pattern out of hours: a survey of general practice cooperatives. BMJ (1997) 1.80
Reduction in sudden infant death syndrome in Scotland. Lancet (1992) 1.72
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.70
Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol (1993) 1.66
Responses of the isolated anococcygeus muscle of the mouse to drugs and to field stimulation. J Auton Pharmacol (1981) 1.64
Down your drink: a web-based intervention for people with excessive alcohol consumption. Alcohol Alcohol (2003) 1.62
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion. BMJ (2003) 1.62
L-NG-nitro-arginine and its methyl ester are potent inhibitors of non-adrenergic, non-cholinergic transmission in the rat anococcygeus. Br J Pharmacol (1990) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The effects of drugs on the sensitivity of the rat anococcygeus muscle to agonists. Br J Pharmacol (1973) 1.53
Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance. Clin Exp Allergy (2011) 1.53
Electrolytes and water in the brain and cerebrospinal fluid of the foetal sheep and guinea-pig. J Physiol (1972) 1.50
Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology. J Virol Methods (2000) 1.50
Health targets in the NHS: lessons learned from experience with breast feeding targets in Scotland. BMJ (1997) 1.48
Relative analgesia. An evaluation of the efficacy and safety. Br Dent J (1979) 1.48
Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis (2003) 1.48
Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry (1996) 1.45
Three-dimensional electrical impedance tomography of human brain activity. Neuroimage (2001) 1.45
Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest (1986) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes (1986) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Complete recovery from hemorrhagic shock and encephalopathy. J Pediatr (1992) 1.40
Two distinct membrane currents activated by cyclopiazonic acid-induced calcium store depletion in single smooth muscle cells of the mouse anococcygeus. Br J Pharmacol (1996) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Coping with patients' problem drinking. Practitioner (1989) 1.39
Blood pressure, smoking, obesity and alcohol consumption in black and white patients in general practice. J Hum Hypertens (1987) 1.38
Minimum Standards for Training: A consumer viewpoint. Br Med J (Clin Res Ed) (1985) 1.37
Embedding guidelines into direct physician order entry: simple methods, powerful results. Proc AMIA Symp (1999) 1.37
Tracheo-innominate artery erosion: Successful surgical management of a devastating complication. Ann Surg (1976) 1.37
Don't wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin Oncol (R Coll Radiol) (2002) 1.37
Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest (1990) 1.36
Complex effects of Gillichthys urotensin II on rat aortic strips. Br J Pharmacol (1987) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Pediatric falls from heights. J Trauma (1991) 1.34
An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus. Br J Pharmacol (1992) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Neurogenic tumors of the thorax. Surg Clin North Am (1988) 1.31
Effects of limb-length discrepancy on gait economy and lower-extremity muscle activity in older adults. J Bone Joint Surg Am (2001) 1.30
Creatinuria in Certain Diseased Conditions. Can Med Assoc J (1922) 1.29
Performance of different mono- and multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel. J Clin Microbiol (2011) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Major complications after minimally invasive repair of pectus excavatum: case reports. J Pediatr Surg (2001) 1.26
Genetic linkage between Huntington's disease and the DNA polymorphism G8 in South Wales families. J Med Genet (1985) 1.25
Linking up with the over 75s. Br J Gen Pract (1990) 1.25
Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy. J Comp Neurol (1995) 1.25
Patients with alcohol problems--simple questioning is the key to effective identification and management. Br J Gen Pract (2001) 1.24
The "critical" neonate with diaphragmatic hernia: a 21-year perspective. J Pediatr Surg (1984) 1.22
Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non-vascular smooth muscle: role of superoxide anions. Br J Pharmacol (1991) 1.21
Chronic fatigue in general practice: economic evaluation of counselling versus cognitive behaviour therapy. Br J Gen Pract (2001) 1.21
The involvement of corticosteroids in the supersensitivity produced in the rat anococcygeus muscle by morphine withdrawal, thyroidectomy or a single dose of reserpine. J Pharmacol Exp Ther (1975) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
The nature of potassium chloride-induced relaxations of the rat anococcygeus muscle. Br J Pharmacol (1977) 1.19
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab (1990) 1.18
Capacitative Ca2+ entry and the regulation of smooth muscle tone. Trends Pharmacol Sci (1998) 1.18
Long term survival after intensive care. BMJ (1990) 1.17
Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen Comp Endocrinol (1986) 1.17